Promising Long-Term Health-Related Quality of Life After High-Dose-Rate Brachytherapy Boost for Localized Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 3, 2007, Pages 662-670

  Wahlgren, Thomas ^a   Nilsson, Sten ^a   Lennernäs, Bo ^b   Brandberg, Yvonne ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Health related quality of life; High dose rate brachytherapy; Localized prostate cancer; Questionnaire; Radiotherapy; Side effects

Indexed keywords

DISEASES; HORMONES; MULTIVARIANT ANALYSIS; PROBLEM SOLVING; RADIOTHERAPY;

HEALTH-RELATED QUALITY; HIGH-DOSE-RATE BRACHYTHERAPY; LOCALIZED PROSTATE CANCER; QUESTIONNAIRE; SIDE EFFECTS;

ONCOLOGY;

ANTIANDROGEN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DIARRHEA; ERECTILE DYSFUNCTION; FECES INCONTINENCE; GROUPS BY AGE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PAIN; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE INDEX; RADIATION DOSE; SLEEP DISORDER; SOCIAL STATUS; STATISTICAL ANALYSIS; URINARY URGENCY;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BRACHYTHERAPY; ERECTILE DYSFUNCTION; FECAL INCONTINENCE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 34548703114     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.001     Document Type: Article

References (23)

1. Fowler Jr. F.J., Barry M.J., Lu-Yao G., et al. Patient-reported complications and follow-up treatment after radical prostatectomy: The national Medicare experience: 1988-1990 (updated June 1993). Urology 42 (1993) 622-629
2. Fowler Jr. F.J., Barry M.J., Lu-Yao G., et al. Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three Surveillance, Epidemiology, and End Results areas. J Clin Oncol 14 (1996) 2258-2265
3. Efficace F., Bottomley A., and van Andel G. Health related quality of life in prostate carcinoma patients: A systematic review of randomized controlled trials. Cancer 97 (2003) 377-388
4. Borghede G., Hedelin H., Holmang S., et al. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. Radiother Oncol 44 (1997) 245-250
5. Wahlgren T., Brandberg Y., Haggarth L., et al. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)Ir brachytherapy: A prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25. Int J Radiat Oncol Biol Phys 60 (2004) 51-59
6. Wahlgren T., Nilsson S., Ryberg M., et al. Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer: A prospective assessment of acute and late treatment toxicity. Acta Oncol 44 (2005) 633-643
7. Galalae R.M., Loch T., Riemer B., et al. Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer. Strahlenther Onkol 180 (2004) 582-589
8. Joly F., Brune D., Couette J.E., et al. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer. Ann Oncol 9 (1998) 751-757
9. Michelson H., Bolund C., Nilsson B., et al. Health-related quality of life measured by the EORTC QLQ-C30-Reference values from a large sample of Swedish population. Acta Oncol 39 (2000) 477-484
10. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
11. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
12. Aaronson NK, van Andel G. EORTC Genito Urinary Tract Cancer Group - An international field of the reliability and validity of the QLQ-C30 and a disease-specific questionnaire module (QLQ-PR25) for assessing quality of life of patients with prostate cancer. European Organization for Research and Treatment of Cancer study protocol (15011), Brussels, 2002.
13. al-Abany M., Helgason A.R., Adolfsson J., et al. Reliability of assessment of urgency and other symptoms indicating anal sphincter, large bowel or urinary dysfunction. Scand J Urol Nephrol 40 (2006) 397-408
14. Rubin P., Constine III L.S., Fajardo L.F., et al., for the EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 35 (1995) 9-10
15. Fayers P., Aaronson N.K., Bjordal K., et al. EORTC QLQ-C30 scoring manual (1997), EORTC Publications, Brussels
16. Osoba D., Rodrigues G., Myles J., et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16 (1998) 139-144
17. Neymark N., Kiebert W., Torfs K., et al. Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: Report of a workshop. Eur J Cancer 34 (1998) 1317-1333
18. Schwartz C.E., and Sprangers M.A. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 48 (1999) 1531-1548
19. Fransson P., and Widmark A. Self-assessed sexual function after pelvic irradiation for prostate carcinoma: Comparison with an age-matched control group. Cancer 78 (1996) 1066-1078
20. Lennernäs B., Holmang S., and Hedelin H. High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one center. Strahlenther Onkol 178 (2002) 537-541
21. al-Abany M., Helgason A.R., Cronqvist A.K., et al. Dose to the anal sphincter region and risk of fecal leakage. Acta Oncol 43 (2004) 117-118
22. Miller D.C., Sanda M.G., Dunn R.L., et al. Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 23 (2005) 2772-2780
23. Fransson P., and Widmark A. Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma: A comparison with age-matched controls. Cancer 85 (1999) 678-688